drugset / Trial / NCT00622570

Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension

NCT00622570

RandomizedParallel-groupSingle-blindTreatment

Summary

Objective: to assess the effectiveness of pentobarbital and thiopental to control raised intracranial pressure (ICP), refractory to first level measures, in patients with severe traumatic brain injury. Material and methods: prospective, randomized open study to compare the effectiveness between two treatments: pentobarbital and thiopental. The patients will be selected from those admitted to the Intensive Care Unit with a severe traumatic brain injury (postresuscitation Glasgow Coma Scale equal or less than 8 points) and raised ICP (ICP\>20 mmHg) refractory to first level measures according to the Brain Trauma Foundation guidelines. The adverse effects of both treatments were also collected.

Timeline

Start
2002-05
Primary completion
2007-07
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentobarbital Small molecule 1 mg/kg
Comparator Thiopental Small molecule 3 mg/kg